Press Releases

All Releases
View Summary Ironwood And Forest To Present Additional Phase 2b Data For Novel Gastrointestinal Agent Linaclotide
May 12, 2009
PDF 17.7 KB Add to Briefcase
View Summary Ironwood Announces Linaclotide European Licensing Agreement With Almirall
May 4, 2009
PDF 15.9 KB Add to Briefcase
  Ironwood Presents Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
Oct 21, 2008
PDF 137.5 KB Add to Briefcase
  Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
Oct 7, 2008
PDF 147.7 KB Add to Briefcase
  Ironwood and Collaborators Present Preclinical Data Demonstrating that Cyclic GMP Alleviates Intestinal Pain
Oct 6, 2008
PDF 135.1 KB Add to Briefcase
  Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
Oct 1, 2008
PDF 135.6 KB Add to Briefcase
  Ironwood and Forest to Present Positive Data from Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
Sep 23, 2008
PDF 146.5 KB Add to Briefcase
  Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
May 20, 2008
PDF 180.6 KB Add to Briefcase
  Microbia Announces Name Change to Ironwood Pharmaceuticals
Apr 7, 2008
PDF 32.1 KB Add to Briefcase
  Microbia Appoints Halley Gilbert as Vice President, General Counsel
Mar 31, 2008
PDF 39.7 KB Add to Briefcase
  Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2B Studies
Mar 4, 2008
PDF 49.7 KB Add to Briefcase
Showing 221-231 of 231 Page: 1 ... 8 9 10 11 12  Previous 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.